These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 16436749)

  • 21. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
    Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus.
    Boos M; Mayer S; Fischer A; Köhrer K; Scheuring S; Heisig P; Verhoef J; Fluit AC; Schmitz FJ
    Antimicrob Agents Chemother; 2001 Mar; 45(3):938-42. PubMed ID: 11181385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characteristics and in vitro susceptibility to antimicrobial agents, including the des-fluoro(6) quinolone DX-619, of Panton-Valentine leucocidin-positive methicillin-resistant Staphylococcus aureus isolates from the community and hospitals.
    Yamamoto T; Dohmae S; Saito K; Otsuka T; Takano T; Chiba M; Fujikawa K; Tanaka M
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4077-86. PubMed ID: 17043124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
    Levy DD; Sharma B; Cebula TA
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2355-63. PubMed ID: 15215081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of DX-619, a des-F(6)-quinolone, against Helicobacter pylori.
    Takano T; Higuchi W; Kanda H; Yamamoto T
    J Antimicrob Chemother; 2011 Jan; 66(1):220-2. PubMed ID: 21044976
    [No Abstract]   [Full Text] [Related]  

  • 27. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
    Pan XS; Yague G; Fisher LM
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3140-7. PubMed ID: 11600369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant prevention concentrations of ABT-492, levofloxacin, moxifloxacin, and gatifloxacin against three common respiratory pathogens.
    Hermsen ED; Hovde LB; Konstantinides GN; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1633-5. PubMed ID: 15793158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bactericidal activity of garenoxacin tested by kill-curve methodology against wild type and QRDR mutant strains of Streptococcus pneumoniae.
    Anderegg TR; Jones RN
    Diagn Microbiol Infect Dis; 2004 Nov; 50(3):213-7. PubMed ID: 15541608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The anti-methicillin-resistant Staphylococcus aureus quinolone WCK 771 has potent activity against sequentially selected mutants, has a narrow mutant selection window against quinolone-resistant Staphylococcus aureus, and preferentially targets DNA gyrase.
    Bhagwat SS; Mundkur LA; Gupte SV; Patel MV; Khorakiwala HF
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3568-79. PubMed ID: 16940059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The new 4-quinolones DU-6859a and DV-7751a show enhanced activity against Streptococcus pneumoniae.
    Morrissey I; Smith JT
    Drugs; 1995; 49 Suppl 2():228-9. PubMed ID: 8549312
    [No Abstract]   [Full Text] [Related]  

  • 32. Induction of in vitro resistance to BMS-284756 by Streptococcus pneumoniae.
    Schmitz FJ; Boos M; Jagusch H; Mayer S; Fluit AC; Hafner D
    J Antimicrob Chemother; 2001 Oct; 48(4):588-90. PubMed ID: 11581245
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of AUC/MIC ratios on the pharmacodynamics of the des-F(6) quinolone garenoxacin (BMS-284756) is similar to other fluoroquinolones.
    Lister PD
    J Antimicrob Chemother; 2003 Jan; 51(1):199-202. PubMed ID: 12493819
    [No Abstract]   [Full Text] [Related]  

  • 34. Selection of quinolone-resistant mutants of Haemophilus influenzae and Streptococcus pneumoniae.
    Piddock LJ; Jin YF
    J Antimicrob Chemother; 1992 Jul; 30(1):109-10. PubMed ID: 1429332
    [No Abstract]   [Full Text] [Related]  

  • 35. Quinolone-resistance mechanisms and in vitro susceptibility patterns among European isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniae.
    Schmitz FJ; Fisher A; Boos M; Mayer S; Milatovic D; Fluit AC
    Eur J Clin Microbiol Infect Dis; 2001 Mar; 20(3):219-22. PubMed ID: 11347679
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical application of a ligation-independent pathway of multiplex ligation-dependent probe amplification for the determination of quinolone susceptibility of Streptococcus pneumoniae.
    Uno N; Araki N; Kaku N; Kosai K; Hasegawa H; Yanagihara K
    J Microbiol Methods; 2016 Sep; 128():13-15. PubMed ID: 27343683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of the novel des-F(6) quinolone BMS-284756 against genetically characterized clinical streptococcal isolates, including isolates with reduced quinolone susceptibility.
    Schmitz FJ; Milatovic D; Boos M; Mayer S; Fluit AC
    J Antimicrob Chemother; 2002 Apr; 49(4):698-701. PubMed ID: 11909849
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis and structure-activity relationships of 7-[3-(1-aminoalkyl)pyrrolidinyl]- and 7-[3-1-aminocycloalkyl)pyrrolidinyl]-quinolone antibacterials.
    Kimura Y; Atarashi S; Takahashi M; Hayakawa I
    Chem Pharm Bull (Tokyo); 1994 Jul; 42(7):1442-54. PubMed ID: 7923467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular penetration and bactericidal activity of the novel des-fluoro(6) quinolone, BMS-284756.
    Kolek B; Warr G; Bonner D; Fung-Tomc J
    J Antimicrob Chemother; 2001 Sep; 48(3):445-6. PubMed ID: 11533015
    [No Abstract]   [Full Text] [Related]  

  • 40. Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.
    Van Bambeke F; Reinert RR; Appelbaum PC; Tulkens PM; Peetermans WE
    Drugs; 2007; 67(16):2355-82. PubMed ID: 17983256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.